Carnauba Wax Tablet Base Material for Clean Medicine Formulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a market gap for organic pharmaceutical tablets that are minimally processed and free from synthetic or artificial ingredients, which are perceived as 'clean medicines' but have been elusive in the market.
Innovation Solution
Formulations of solid tablets using carnauba wax as a primary base material, combined with edible oils, rice bran-based excipients, and active pharmaceutical ingredients, with a focus on achieving specific hardness and composition ratios to ensure stability and effectiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If traditional excipients and processing methods are used in tablet formulation, then manufacturing feasibility and dosage form stability are achieved, but synthetic or artificial ingredients are introduced which contradicts the 'clean medicine' concept
Solution Approach 1:
The patent changes the chemical composition parameters by replacing traditional synthetic excipients with natural alternatives. Specifically, it uses carnauba wax as a base material instead of conventional binders, and incorporates natural ingredients like rice bran, dextrose, and edible oils to achieve stable tablet formulations without synthetic components.
Solution Approach 2:
The patent creates a composite material system using carnauba wax as the primary base material combined with natural excipients including rice bran, dextrose, gum Arabic, and edible oils. This composite approach maintains tablet stability while adhering to the clean medicine concept by using only natural, minimally processed ingredients.
2Object-generated harmful factors
If natural ingredients are used to create organic pharmaceutical tablets, then the clean medicine concept is achieved, but tablet hardness and structural integrity may be compromised
Solution Approach 1:
The patent optimizes the concentration parameters of natural ingredients to achieve desired hardness. It specifies that carnauba wax should constitute 50-80% of the base material, with the active ingredient comprising greater than 90% of the tablet by weight, and adjusts these parameters to achieve hardness between 50N and 90N.
Solution Approach 2:
The patent employs a composite material system where carnauba wax serves as the primary structural base material providing hardness and integrity, combined with natural excipients like rice bran, dextrose, and edible oils that maintain the clean medicine concept while contributing to overall tablet strength through their complementary properties.
3Reliability
If high concentration of active ingredient is used in the tablet, then therapeutic effectiveness is improved, but tablet structural stability and manufacturability may be affected
Solution Approach 1:
The patent sets the active ingredient concentration at greater than 90% by weight of the tablet, which is an extreme parameter change from conventional formulations. This high concentration is achieved by using carnauba wax as the base material containing the active ingredient, with the formulation consisting essentially of only the active material and base material, thereby maintaining both effectiveness and stability.
4Object-generated harmful factors
If minimally processed natural ingredients are used, then the organic pharmaceutical concept is achieved, but manufacturing precision and consistency may be reduced
Solution Approach 1:
The patent specifies precise parameter ranges for natural ingredients to ensure manufacturing consistency. It defines carnauba wax content as 50-80% of base material, active ingredient as greater than 90% of tablet weight, and hardness between 50N and 90N, providing clear manufacturing targets that maintain both natural ingredient integrity and formulation precision.
Solution Approach 2:
The patent uses a composite material system with carnauba wax as the primary base material that provides structural consistency, combined with natural excipients including rice bran, dextrose, gum Arabic, and edible oils. This composite approach maintains minimally processed ingredients while achieving manufacturing precision through the stabilizing properties of the carnauba wax matrix.
Data Source
AI summary
A tablet includes an active material and a base material comprising carnauba wax and an oil. A tablet formulation can contain an active pharmaceutical ingredient and a base material that includes carnauba wax. The carnauba wax constitutes more than 50% of the base material.